APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iridoids

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iridoids Market Outlook and Growth Opportunities 2026

27 December 2025194 pages

Choose your research edition.

Industry ResearchIridoids Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Iridoids Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Iridoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iridoids Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Iridoids Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Iridoids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iridoids market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iridoids market include Wuhan Chengyuan Pharmaceutical Co, Shaanxi Sciphar Hi-Tech, Lunan Pharmaceutical Group, Kemin Industries, Sigma-Aldrich, Nexira, Martin Bauer Group, LKT Labs and Layn Natural Ingredients, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iridoids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iridoids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iridoids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iridoids market size, projected growth trends, production technologies, key applications, and end-use industries.

Iridoids Segment by Company

Wuhan Chengyuan Pharmaceutical Co

Shaanxi Sciphar Hi-Tech

Lunan Pharmaceutical Group

Kemin Industries

Sigma-Aldrich

Nexira

Martin Bauer Group

LKT Labs

Layn Natural Ingredients

Indena

Enzo Life Sciences

Dalian Sky Chemical

Iridoids Segment by Type

Natural

Synthesis

Iridoids Segment by Application

Drugs

Health Products

Others

Iridoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Iridoids status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iridoids market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iridoids significant trends, drivers, influence factors in global and regions.

6. To analyze Iridoids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iridoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iridoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iridoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iridoids market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iridoids industry.

Chapter 3: Detailed analysis of Iridoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iridoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iridoids in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iridoids Industry Trends Table 2. Iridoids Industry Drivers Table 3. Iridoids Industry Opportunities and Challenges Table 4. Iridoids Industry Restraints Table 5. Global Iridoids Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iridoids Revenue Share by Company (2021-2026) Table 7. Global Iridoids Sales Volume by Company (t) & (2021-2026) Table 8. Global Iridoids Sales Volume Share by Company (2021-2026) Table 9. Global Iridoids Average Price (USD/t) of Company (2021-2026) Table 10. Global Iridoids Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iridoids Key Company Manufacturing Base & Headquarters Table 12. Global Iridoids Company, Product Type & Application Table 13. Global Iridoids Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iridoids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Natural Table 18. Significant Companies of Synthesis Table 19. Global Iridoids Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Iridoids Sales Volume by Type (2021-2026) & (t) Table 21. Global Iridoids Sales Volume by Type (2027-2032) & (t) Table 22. Global Iridoids Sales Volume Share by Type (2021-2026) Table 23. Global Iridoids Sales Volume Share by Type (2027-2032) Table 24. Global Iridoids Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Iridoids Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Iridoids Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Iridoids Sales Value Share by Type (2021-2026) Table 28. Global Iridoids Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Drugs Table 30. Significant Companies of Health Products Table 31. Significant Companies of Others Table 32. Global Iridoids Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Iridoids Sales Volume by Application (2021-2026) & (t) Table 34. Global Iridoids Sales Volume by Application (2027-2032) & (t) Table 35. Global Iridoids Sales Volume Share by Application (2021-2026) Table 36. Global Iridoids Sales Volume Share by Application (2027-2032) Table 37. Global Iridoids Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Iridoids Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Iridoids Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Iridoids Sales Value Share by Application (2021-2026) Table 41. Global Iridoids Sales Value Share by Application (2027-2032) Table 42. Global Iridoids Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Iridoids Sales by Region (2021-2026) & (t) Table 44. Global Iridoids Sales Market Share by Region (2021-2026) Table 45. Global Iridoids Sales by Region (2027-2032) & (t) Table 46. Global Iridoids Sales Market Share by Region (2027-2032) Table 47. Global Iridoids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Iridoids Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Iridoids Sales Value Share by Region (2021-2026) Table 50. Global Iridoids Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Iridoids Sales Value Share by Region (2027-2032) Table 52. Global Iridoids Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Iridoids Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Iridoids Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global Iridoids Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Iridoids Sales by Country (2021-2026) & (t) Table 57. Global Iridoids Sales Market Share by Country (2021-2026) Table 58. Global Iridoids Sales by Country (2027-2032) & (t) Table 59. Global Iridoids Sales Market Share by Country (2027-2032) Table 60. Global Iridoids Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Iridoids Sales Value Market Share by Country (2021-2026) Table 62. Global Iridoids Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Iridoids Sales Value Market Share by Country (2027-2032) Table 64. Wuhan Chengyuan Pharmaceutical Co Company Information Table 65. Wuhan Chengyuan Pharmaceutical Co Business Overview Table 66. Wuhan Chengyuan Pharmaceutical Co Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Wuhan Chengyuan Pharmaceutical Co Iridoids Product Portfolio Table 68. Wuhan Chengyuan Pharmaceutical Co Recent Development Table 69. Shaanxi Sciphar Hi-Tech Company Information Table 70. Shaanxi Sciphar Hi-Tech Business Overview Table 71. Shaanxi Sciphar Hi-Tech Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Shaanxi Sciphar Hi-Tech Iridoids Product Portfolio Table 73. Shaanxi Sciphar Hi-Tech Recent Development Table 74. Lunan Pharmaceutical Group Company Information Table 75. Lunan Pharmaceutical Group Business Overview Table 76. Lunan Pharmaceutical Group Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Lunan Pharmaceutical Group Iridoids Product Portfolio Table 78. Lunan Pharmaceutical Group Recent Development Table 79. Kemin Industries Company Information Table 80. Kemin Industries Business Overview Table 81. Kemin Industries Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Kemin Industries Iridoids Product Portfolio Table 83. Kemin Industries Recent Development Table 84. Sigma-Aldrich Company Information Table 85. Sigma-Aldrich Business Overview Table 86. Sigma-Aldrich Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Sigma-Aldrich Iridoids Product Portfolio Table 88. Sigma-Aldrich Recent Development Table 89. Nexira Company Information Table 90. Nexira Business Overview Table 91. Nexira Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Nexira Iridoids Product Portfolio Table 93. Nexira Recent Development Table 94. Martin Bauer Group Company Information Table 95. Martin Bauer Group Business Overview Table 96. Martin Bauer Group Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Martin Bauer Group Iridoids Product Portfolio Table 98. Martin Bauer Group Recent Development Table 99. LKT Labs Company Information Table 100. LKT Labs Business Overview Table 101. LKT Labs Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. LKT Labs Iridoids Product Portfolio Table 103. LKT Labs Recent Development Table 104. Layn Natural Ingredients Company Information Table 105. Layn Natural Ingredients Business Overview Table 106. Layn Natural Ingredients Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Layn Natural Ingredients Iridoids Product Portfolio Table 108. Layn Natural Ingredients Recent Development Table 109. Indena Company Information Table 110. Indena Business Overview Table 111. Indena Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Indena Iridoids Product Portfolio Table 113. Indena Recent Development Table 114. Enzo Life Sciences Company Information Table 115. Enzo Life Sciences Business Overview Table 116. Enzo Life Sciences Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Enzo Life Sciences Iridoids Product Portfolio Table 118. Enzo Life Sciences Recent Development Table 119. Dalian Sky Chemical Company Information Table 120. Dalian Sky Chemical Business Overview Table 121. Dalian Sky Chemical Iridoids Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. Dalian Sky Chemical Iridoids Product Portfolio Table 123. Dalian Sky Chemical Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Iridoids Distributors List Table 127. Iridoids Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Iridoids Product Image Figure 2. Global Iridoids Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iridoids Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iridoids Sales (2021-2032) & (t) Figure 5. Global Iridoids Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Iridoids Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Natural Image Figure 10. Synthesis Image Figure 11. Global Iridoids Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Iridoids Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Iridoids Sales Volume Share by Type (2021-2032) Figure 14. Global Iridoids Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Iridoids Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Iridoids Sales Value Share by Type (2021-2032) Figure 17. Drugs Image Figure 18. Health Products Image Figure 19. Others Image Figure 20. Global Iridoids Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Iridoids Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Iridoids Sales Volume Share by Application (2021-2032) Figure 23. Global Iridoids Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Iridoids Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Iridoids Sales Value Share by Application (2021-2032) Figure 26. Global Iridoids Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Iridoids Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Iridoids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Iridoids Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Iridoids Sales Value (2021-2032) & (US$ Million) Figure 31. North America Iridoids Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Iridoids Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Iridoids Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Iridoids Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Iridoids Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Iridoids Sales Value (2021-2032) & (US$ Million) Figure 37. South America Iridoids Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Iridoids Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Iridoids Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Iridoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Iridoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Iridoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iridoids Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Iridoids Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Natural
  • Synthesis
Applications
  • Drugs
  • Health Products
  • Others
Companies covered
  • Wuhan Chengyuan Pharmaceutical Co
  • Shaanxi Sciphar Hi-Tech
  • Lunan Pharmaceutical Group
  • Kemin Industries
  • Sigma-Aldrich
  • Nexira
  • Martin Bauer Group
  • LKT Labs
  • Layn Natural Ingredients
  • Indena
  • Enzo Life Sciences
  • Dalian Sky Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iridoids Sales Value (2021-2032)
  4. 1.2.2 Global Iridoids Sales Volume (2021-2032)
  5. 1.2.3 Global Iridoids Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iridoids Market Dynamics
  1. 2.1 Iridoids Industry Trends
  2. 2.2 Iridoids Industry Drivers
  3. 2.3 Iridoids Industry Opportunities and Challenges
  4. 2.4 Iridoids Industry Restraints
3 Iridoids Market by Company
  1. 3.1 Global Iridoids Company Revenue Ranking in 2025
  2. 3.2 Global Iridoids Revenue by Company (2021-2026)
  3. 3.3 Global Iridoids Sales Volume by Company (2021-2026)
  4. 3.4 Global Iridoids Average Price by Company (2021-2026)
  5. 3.5 Global Iridoids Company Ranking (2024-2026)
  6. 3.6 Global Iridoids Company Manufacturing Base and Headquarters
  7. 3.7 Global Iridoids Company Product Type and Application
  8. 3.8 Global Iridoids Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iridoids Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iridoids Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iridoids Market by Type
  1. 4.1 Iridoids Type Introduction
  2. 4.1.1 Natural
  3. 4.1.2 Synthesis
  4. 4.2 Global Iridoids Sales Volume by Type
  5. 4.2.1 Global Iridoids Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Iridoids Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Iridoids Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Iridoids Sales Value by Type
  9. 4.3.1 Global Iridoids Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Iridoids Sales Value by Type (2021-2032)
  11. 4.3.3 Global Iridoids Sales Value Share by Type (2021-2032)
5 Iridoids Market by Application
  1. 5.1 Iridoids Application Introduction
  2. 5.1.1 Drugs
  3. 5.1.2 Health Products
  4. 5.1.3 Others
  5. 5.2 Global Iridoids Sales Volume by Application
  6. 5.2.1 Global Iridoids Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Iridoids Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Iridoids Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Iridoids Sales Value by Application
  10. 5.3.1 Global Iridoids Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Iridoids Sales Value by Application (2021-2032)
  12. 5.3.3 Global Iridoids Sales Value Share by Application (2021-2032)
6 Iridoids Regional Sales and Value Analysis
  1. 6.1 Global Iridoids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iridoids Sales by Region (2021-2032)
  3. 6.2.1 Global Iridoids Sales by Region: 2021-2026
  4. 6.2.2 Global Iridoids Sales by Region (2027-2032)
  5. 6.3 Global Iridoids Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iridoids Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iridoids Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iridoids Sales Value by Region (2027-2032)
  9. 6.5 Global Iridoids Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iridoids Sales Value (2021-2032)
  12. 6.6.2 North America Iridoids Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iridoids Sales Value (2021-2032)
  15. 6.7.2 Europe Iridoids Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iridoids Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iridoids Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iridoids Sales Value (2021-2032)
  21. 6.9.2 South America Iridoids Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iridoids Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iridoids Sales Value Share by Country, 2025 VS 2032
7 Iridoids Country-level Sales and Value Analysis
  1. 7.1 Global Iridoids Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iridoids Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iridoids Sales by Country (2021-2032)
  4. 7.3.1 Global Iridoids Sales by Country (2021-2026)
  5. 7.3.2 Global Iridoids Sales by Country (2027-2032)
  6. 7.4 Global Iridoids Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iridoids Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iridoids Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iridoids Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iridoids Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iridoids Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iridoids Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iridoids Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iridoids Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iridoids Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iridoids Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iridoids Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iridoids Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iridoids Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iridoids Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iridoids Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iridoids Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iridoids Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iridoids Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iridoids Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iridoids Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iridoids Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iridoids Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iridoids Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iridoids Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iridoids Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iridoids Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iridoids Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iridoids Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iridoids Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iridoids Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iridoids Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iridoids Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iridoids Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iridoids Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iridoids Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iridoids Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iridoids Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iridoids Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iridoids Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iridoids Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iridoids Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iridoids Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iridoids Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iridoids Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iridoids Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iridoids Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iridoids Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iridoids Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iridoids Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iridoids Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iridoids Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iridoids Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iridoids Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iridoids Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iridoids Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iridoids Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iridoids Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iridoids Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iridoids Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iridoids Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iridoids Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iridoids Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iridoids Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iridoids Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iridoids Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iridoids Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iridoids Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iridoids Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iridoids Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iridoids Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iridoids Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iridoids Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iridoids Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iridoids Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iridoids Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iridoids Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iridoids Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iridoids Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iridoids Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iridoids Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iridoids Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iridoids Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iridoids Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iridoids Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iridoids Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iridoids Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Chengyuan Pharmaceutical Co
  2. 8.1.1 Wuhan Chengyuan Pharmaceutical Co Company Information
  3. 8.1.2 Wuhan Chengyuan Pharmaceutical Co Business Overview
  4. 8.1.3 Wuhan Chengyuan Pharmaceutical Co Iridoids Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Chengyuan Pharmaceutical Co Iridoids Product Portfolio
  6. 8.1.5 Wuhan Chengyuan Pharmaceutical Co Recent Developments
  7. 8.2 Shaanxi Sciphar Hi-Tech
  8. 8.2.1 Shaanxi Sciphar Hi-Tech Company Information
  9. 8.2.2 Shaanxi Sciphar Hi-Tech Business Overview
  10. 8.2.3 Shaanxi Sciphar Hi-Tech Iridoids Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shaanxi Sciphar Hi-Tech Iridoids Product Portfolio
  12. 8.2.5 Shaanxi Sciphar Hi-Tech Recent Developments
  13. 8.3 Lunan Pharmaceutical Group
  14. 8.3.1 Lunan Pharmaceutical Group Company Information
  15. 8.3.2 Lunan Pharmaceutical Group Business Overview
  16. 8.3.3 Lunan Pharmaceutical Group Iridoids Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lunan Pharmaceutical Group Iridoids Product Portfolio
  18. 8.3.5 Lunan Pharmaceutical Group Recent Developments
  19. 8.4 Kemin Industries
  20. 8.4.1 Kemin Industries Company Information
  21. 8.4.2 Kemin Industries Business Overview
  22. 8.4.3 Kemin Industries Iridoids Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kemin Industries Iridoids Product Portfolio
  24. 8.4.5 Kemin Industries Recent Developments
  25. 8.5 Sigma-Aldrich
  26. 8.5.1 Sigma-Aldrich Company Information
  27. 8.5.2 Sigma-Aldrich Business Overview
  28. 8.5.3 Sigma-Aldrich Iridoids Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sigma-Aldrich Iridoids Product Portfolio
  30. 8.5.5 Sigma-Aldrich Recent Developments
  31. 8.6 Nexira
  32. 8.6.1 Nexira Company Information
  33. 8.6.2 Nexira Business Overview
  34. 8.6.3 Nexira Iridoids Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nexira Iridoids Product Portfolio
  36. 8.6.5 Nexira Recent Developments
  37. 8.7 Martin Bauer Group
  38. 8.7.1 Martin Bauer Group Company Information
  39. 8.7.2 Martin Bauer Group Business Overview
  40. 8.7.3 Martin Bauer Group Iridoids Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Martin Bauer Group Iridoids Product Portfolio
  42. 8.7.5 Martin Bauer Group Recent Developments
  43. 8.8 LKT Labs
  44. 8.8.1 LKT Labs Company Information
  45. 8.8.2 LKT Labs Business Overview
  46. 8.8.3 LKT Labs Iridoids Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LKT Labs Iridoids Product Portfolio
  48. 8.8.5 LKT Labs Recent Developments
  49. 8.9 Layn Natural Ingredients
  50. 8.9.1 Layn Natural Ingredients Company Information
  51. 8.9.2 Layn Natural Ingredients Business Overview
  52. 8.9.3 Layn Natural Ingredients Iridoids Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Layn Natural Ingredients Iridoids Product Portfolio
  54. 8.9.5 Layn Natural Ingredients Recent Developments
  55. 8.10 Indena
  56. 8.10.1 Indena Company Information
  57. 8.10.2 Indena Business Overview
  58. 8.10.3 Indena Iridoids Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Indena Iridoids Product Portfolio
  60. 8.10.5 Indena Recent Developments
  61. 8.11 Enzo Life Sciences
  62. 8.11.1 Enzo Life Sciences Company Information
  63. 8.11.2 Enzo Life Sciences Business Overview
  64. 8.11.3 Enzo Life Sciences Iridoids Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Enzo Life Sciences Iridoids Product Portfolio
  66. 8.11.5 Enzo Life Sciences Recent Developments
  67. 8.12 Dalian Sky Chemical
  68. 8.12.1 Dalian Sky Chemical Company Information
  69. 8.12.2 Dalian Sky Chemical Business Overview
  70. 8.12.3 Dalian Sky Chemical Iridoids Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Dalian Sky Chemical Iridoids Product Portfolio
  72. 8.12.5 Dalian Sky Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iridoids Value Chain Analysis
  2. 9.1.1 Iridoids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iridoids Sales Mode & Process
  6. 9.2 Iridoids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iridoids Distributors
  9. 9.2.3 Iridoids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst